Lancet 2001 Aug 18; 358 (9281): 527–33PubMedCrossRef 18. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 Selleck Ruboxistaurin Nov 16; 348 (9038):
1329–39CrossRef 19. Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I-Pathophysiological and pharmacological features. Neurosurgery 2000 Jun; 46 (6): 1344–59PubMedCrossRef 20. Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the GW786034 purchase American Heart Association. Circulation 2000 Oct 31; 102 (18): 2300–8PubMedCrossRef 21. Johnston SC, Higashida RT, Barrow DL, et al. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare
professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke 2002 Oct; 33 (10): 2536–44PubMedCrossRef 22. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Lazertinib Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009 Apr 28; 119 (16): 2235–49PubMedCrossRef 23. Soeda A, Sakai N, Sakai H, et al. Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2003 Jan; 24 (1): 127–32PubMed 24. Kang HS, Han MH, Kwon BJ, et al. Is clopidogrel premedication useful to reduce thromboembolic events during coil
embolization for unruptured intracranial aneurysms? Neurosurgery 2010 Nov; 67 (5): 1371–6; discussion 6PubMedCrossRef 25. Hwang G, Jung C, Park SQ, et al. Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural Arachidonate 15-lipoxygenase thromboembolic complication. Neurosurgery 2010 Sep; 67 (3): 743–8; discussion 8PubMedCrossRef 26. Meyers PM, Schumacher HC, Higashida RT, et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. AJNR Am J Neuroradiol 2010 January 1; 31 (1): E12–24PubMed”
“Introduction Bencycloquidium bromide, 3−(2-cyclopentyl-2-hydroxy-2-phenyl) ethoxy−1-methyl−1-azabicyclo [2, 2, 2] octane bromide (BCQB, figure 1), is a novel selective muscarinic M1/M3 receptor antagonist for the treatment of rhinorrhea in rhinitis by intranasal administration.